Related Experiment Video

Updated: Sep 1, 2025

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

1.9K

A new chapter in lipid signaling and kidney fibrosis

Temitayo O Idowu1, Samir M Parikh1

  • 1Division of Nephrology, Departments of Internal Medicine and Pharmacology, University of Texas Southwestern Medical School, 5323 Harry Hines Blvd., Dallas, TX 75390, USA.

Science Translational Medicine
|August 17, 2022
PubMed

Insights

The sphingosine 1-phosphate (S1P) signaling pathway in blood vessels shows promise for treating chronic kidney disease. Targeting this axis offers a potential new therapeutic strategy for kidney disease patients.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pharmacology

Background:

  • Chronic kidney disease (CKD) affects millions globally, necessitating novel therapeutic approaches.
  • The perivascular microenvironment plays a critical role in kidney health and disease progression.
  • Sphingosine 1-phosphate (S1P) signaling is implicated in various physiological and pathological processes.

Purpose of the Study:

  • To investigate the role of the perivascular sphingosine 1-phosphate (S1P) signaling axis in the context of chronic kidney disease.
  • To evaluate the therapeutic potential of targeting the S1P axis for CKD treatment.

Main Methods:

  • Review of existing literature and preclinical data on S1P signaling in kidney disease models.
  • Analysis of the molecular mechanisms linking perivascular S1P pathways to renal pathology.
  • Exploration of potential pharmacological modulators of S1P signaling.

Main Results:

  • The perivascular S1P signaling axis is identified as a key regulator in the pathogenesis of CKD.
  • Evidence suggests that modulating S1P levels or receptor activity can impact disease progression.
  • This pathway represents a druggable target for mitigating kidney damage.

Conclusions:

  • The perivascular S1P signaling axis emerges as a significant and potentially targetable pathway in chronic kidney disease.
  • Targeting this axis offers a promising novel therapeutic strategy for managing and treating kidney disease.

More Related Videos

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis04:37

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

Published on: April 25, 2025

751
Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

2.4K

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
21